Oct 2026· British Journal of Anaesthesia· 0 citations· 40 references
Medicine
TL;DR
Remimazolam-based TIVA met the prespecified criterion for noninferiority to propofol-based TIVA with respect to postoperative delirium after elective neurovascular surgery.
Abstract
Background
Propofol-based total intravenous anaesthesia (TIVA) is commonly used in neurovascular surgery, in which intraoperative neurophysiological monitoring limits inhalation anaesthetic use. However, propofol causes hypotension, and prolonged infusions can delay emergence. Remimazolam, a benzodiazepine whose effects are reversible with flumazenil, has been associated with less intraoperative hypotension than propofol, but its use raises concerns about postoperative delirium (POD). We tested whether remimazolam-based TIVA is noninferior to propofol-based TIVA for POD.
Methods
In this single-centre, double-blind, randomised noninferiority trial, adults undergoing elective intracranial aneurysm clipping, arteriovenous malformation resection, microvascular decompression, or superficial temporal artery-middle cerebral artery bypass received remimazolam-based TIVA with flumazenil reversal at emergence, or propofol-based TIVA, both with remifentanil. The primary outcome was the cumulative incidence of POD within 5 days, assessed twice daily with the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) or the 3-Minute Diagnostic Interview for CAM-defined delirium (3D-CAM). The prespecified noninferiority margin was 10 percentage points.
Results
Among 686 patients in the modified intention-to-treat analysis, POD occurred in 44 of 344 (12.8%) with remimazolam and 37 of 342 (10.8%) with propofol (risk difference, 1.97 percentage points; 95% CI, -2.85 to 6.80; one-sided P<0.001 for noninferiority); per-protocol results were consistent. Hypotensive burden below a mean arterial pressure threshold of 65 mm Hg was lower in the remimazolam group (median, 0 vs 7.5 mm Hg min; P<0.001), and tracheal extubation in the operating room was more frequent (85.2% vs 67.3%).
Conclusions
Remimazolam-based TIVA met the prespecified criterion for noninferiority to propofol-based TIVA with respect to postoperative delirium after elective neurovascular surgery. Interpretation should take into account that the observed incidence of postoperative delirium was lower than anticipated when the noninferiority margin was defined.
CLINICAL TRIAL REGISTRATION
NCT06115031 (ClinicalTrials.gov).
Abstract Introduction Prone spine surgery may increase the risk of cerebral hypoperfusion and postoperative neurological adverse events, particularly in elderly patients. Remimazolam is a novel ultra-short-acting benzodiazepine anaesthetic that may provide greater haemodynamic stability than propofol. However, its effe...
Betina Lazaro, Zhuan Jin, Y. Sugaya et al.· BMJ Open· 0 citations
Background/Objectives: Monitored anesthesia care (MAC) is increasingly used for transcatheter aortic valve replacement (TAVR), where rapid recovery of consciousness may facilitate early postoperative neurological assessment. Remimazolam provides sedation that can be pharmacologically reversed with flumazenil. We compar...
Atsuhiro Kitaura, Takashi Mino, Yukari Yoshino et al.· Journal of Clinical Medicine· 0 citations
Background Postoperative delirium (POD) is a common complication in elderly surgical patients that can impede recovery. While remimazolam offers superior hemodynamic stability compared to propofol, its impact on POD incidence remains unclear. This randomized trial aimed to determine whether two induction doses of remim...
Hong-Na Fan, Xiao-Tong Chen, Lin-Lin Xu et al.· Frontiers in Medicine· 0 citations
ABSTRACT Context: Remimazolam is an ultra-short-acting benzodiazepine used for general anesthesia, including cardiac surgery; however, its effect on postoperative emergence following cardiopulmonary bypass remains unclear. Aims: We aimed to compare postoperative emergence following remimazolam- and propofol-based total...
E. Fujii, Y. Imashuku, Motoi Inoue et al.· Annals of Cardiac Anaesthesi...· 0 citations
The hypothesis-generating findings suggest dexmedetomidine may be a suitable adjunct for anesthesia requiring neuromonitoring, warranting further investigation.
M. I. Shahin, Mohamed Saeed Abd ElAziz, S. El-Fawal et al.· Anesthesia and Pain Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.